Testosterone in first-episode schizophrenia

Neuroendocrinology Letters

Volumn 28, Issue 6, 2007, Pages 811-814

  Češkova, Eva ^a   Přikryl, Radovan ^a   Kašpárek, Tomáš ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

First episode schizophrenia; Negative symptoms; Psychopathology; Testosterone; Treatment

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BIPERIDEN; RISPERIDONE; TESTOSTERONE;

ADULT; ANXIETY; ARTICLE; CHEMOLUMINESCENCE; CORRELATION ANALYSIS; DRUG RESPONSE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUROENDOCRINOLOGY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; TENSION; TESTOSTERONE BLOOD LEVEL; TREATMENT RESPONSE;

EID: 37849006885     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Akhondzadeh S, Rezaei F, Larijani B, Nejatisafa AA, Kashani L, Abbasi SH. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia. Schizophr Res. 2006; 84: 405-410.
2. Ceskova E, Prikryl R, Kasparek T, Ondrusova M. Psychopathology and treatment responsiveness of patients with first-episode schizophrenia. Neuropsychiatric Disease and Treatment. 2005; 1: 179-185
3. Ceškova E, Kašpárek T, Žourková A, Přikryl R. Dexamethasone suppression test in first-episode schizophrenia.Neuroendocrinology Letters. 2006; 27:101-105.
4. Elias A, Kumar A. Testosterone for schizophrenia. Cochrane Database Syst Rev. 2007; 18: CD006197.
5. Friess E, Schiffelholz T, Steckler T, Steiger A. Dehydroepiandrosterone - a neurosteroid. Eur J Clin Invest. 2000; 30 Suppl 3: 46-50.
6. Goyal RO, Sagar R., Ammini AC, Khurana ML, Alias AG. Negative correlation between negative symptoms of schizophrenia and testosterone levels. Ann N Y Acad Sci. 2004; 1032: 291-4.
7. Huber TJ, Tettenborn CH, Leifke E, Emrich HM. Sex hormones in psychotic men. Psychoneuroendocrinology. 2005; 30: 111-114.
8. Kaneda Y. Effects of risperidone on gonadal axis hormones in schizophrenia. Ann Pharmacother. 2001; 35: 1523-1527.
9. Kaneda Y, Fujii A. Effects of chronic neuroleptic administration on the hypothalamo pituitary gonadal adxis of male schizophrenics. Prog Neuropsychopharmacol Biol Psychiatry. 2000; 24: 251-258.
10. Kay S, Fiszbein A, Opler LA. The positive and negative syndrome scale for schizophrenia. Schizophr Bull. 1987; 13: 261-278.
11. King JA, Rosal MC, Ma Y, Reed GW. Association of stress, hostility and plasma testosterone levels. Neuroendocrinol Lett. 2005; 26: 355-60.
12. Ko Y-H, Jung S-W, Joe S-H, Lee Ch-H, Jung H-G, Jung I-K, et al. Association between serum testosterone levels and the Severity of negative symptoms in male patients with chronic schizophrenia. Psychoendocrinology. 2007; 32: 385-391.
13. Melkersson KI, Hultin AL, Rane AJ. Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychosis. Br J Clin Pharmacol. 2001; 51: 317-324.
14. Rau ML, Kolsch H. Effect of estrogen on brain development and neuroprotection - implications for negative symptoms in schizophrenia. Psychoneuroendocrinology. 2003; 28: 83-96.
15. Rinieris P, Hatzimanolis J, Markianos M, Stefanis C. Effects of treatment with various doses of haloperidol on the pituitary-gonadal axis in male schizophrenic patients. Neuropsychobiology. 1989; 22: 146-149.
16. Shirayama Y, Hshimoto K, Suzuki Y, Higuchi T. Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizophr Res. 58, 2002; 58: 69-74.
17. Strous RD, Maayan R, Lapidus R, Goredetsky L, Zeldich E, Kotler M, Weizman A. Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression, and symptomatology. Schizophrenia Res. 2004; 71: 427-434.
18. Taherianfard M, Shariaty M. Evaluation of serum steroid hormones in schizophrenic patients. Indian J Med Sci. 2004; 58: 3-9.
19. Takahashi T, Sakaguchi K, Oki M, Homma S, Hasegawa T. Testosterone levels and discounting delayed monetary gains and losses in male humans. Neuroendocrinol Lett. 2006; 27: 439-444.